Cost-Effectiveness of Adalimumab for Rheumatoid Arthritis in Germany

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.287
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Reply To: Need for Improvements in Reported Cost-Effectiveness of Adalimumab in Rheumatoid Arthritis

Zeitschrift fur Rheumatologie
Rheumatology
2017English

Cost-Effectiveness Analysis of Baricitinib Versus Adalimumab for the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Spain

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2019English

Cost Effectiveness of TNF-αInhibitors in Rheumatoid Arthritis

International Journal of Inflammation
AllergyImmunology
2013English

Pms47 - Cost-Effectiveness of Tofacitinib Compared With Adalimumab in the Treatment of Moderate to Severe Rheumatoid Arthritis in Iran

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of Abatacept Compared to Adalimumab in Italy Based on a Head-To-Head Outcomes Study in Rheumatoid Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

The Cost-Effectiveness of Alternative Treatment Sequences in Rheumatoid Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Adalimumab in the Treatment of Early Rheumatoid Arthritis

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2008English

Pms51 - Cost-Effectiveness of Tofacitinib-Containing Sequences for Rheumatoid Arthritis Patients in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Rheumatoid Arthritis-Associated Uveitis Treated With Adalimumab

Klinika Oczna
MedicineOphthalmology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy